MBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual ...

CamScanner Celebrates National Techies Day with Powerful AI Features and Campus Empowerment Program ...

-- Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in ...

Notice to General Meeting to be held 22 October 2024. See attached announcement 371.

Osisko Announces Agreement to Purchase Royalties on Spartan Resources' Dalgaranga Gold Project in Western Australia ...

Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade Glioma ...

Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ® ), today ...

Casella Waste Systems, Inc. (Nasdaq: CWST), a regional solid waste, recycling, and resource management services company, today announced that it has entered into a $1.5 billion amended and restated ...

Mattermost, Inc., a leader in delivering the secure, real-time collaboration and workflow tools that modern defense, security and intelligence teams need to maintain command, control, and operational ...

Seanergy Maritime Mails Letter to Shareholders Highlighting its Commitment to Delivering Value to All Shareholders ...

IGI Announces CRADA with National Cancer Institute to Test Proprietary Oral Cbl/b Inhibitor Treatment in Triple Negative Breast Cancer ...

Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society ...